“High-frequency migraine refractory to usual pharmacological treatment and antibody and responsive to full-spectrum cannabidiol: a case report”, Headache Med, vol. 13, no. 3, pp. 229–232, Sep. 2022, doi: 10.48208/HeadacheMed.2022.26.